par Gus Iversen
, Editor in Chief | June 14, 2021
From the June 2021 issue of HealthCare Business News magazine
Equipped with a 90 cm CT bore as well, the Celestion PET/CT is designed to support the simulation of radiation treatment planning. It can extend its field of view from 70 cm to 85 cm and uses Canon’s SEMAR technology to reduce metallic artifacts and improve visualization of implants and adjacent soft tissues for clearer and more confident diagnosis.
In 2018, Canon and RaySearch struck up a collaboration to offer Canon’s imaging systems with RayStation, RaySearch’s treatment planning solution. Together, the solutions provide clinicians with information needed to develop treatment plans, including the size and location of the tumor, the direction of radiotherapy beams and appropriate isocenter locations.
IBA teams with NorthStar to increase global access to Tc-99m
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
IBA announced a partnership with radiopharmaceutical developer NorthStar Medical Radioisotopes in March to make technetium-99m more globally available.
The two plan to help non-U.S. companies access NorthStar's Tc-99m generation systems, high tech separation platforms that process non-uranium based Mo-99 as a step in the production of Tc-99m. They are used in conjunction with IBA's electron beam accelerators for reliable commercial-scale production of Mo-99.
"Reliable access to technetium-99m, the most widely used diagnostic imaging radioisotope, is increasingly important as the world's population expands and ages, and the TCM Generation System can help to reliably address these unmet needs on a global basis," Stephen Merrick, president and chief executive officer of NorthStar, told HCB News.
IBA and NorthStar’s partnership builds on an existing contract under which NorthStar will use up to eight Rhodotron TT 300-HE electron beam accelerators developed by IBA for the production of non-uranium based Mo-99. It will then use this Mo-99 in its Tc-99m Generation System, RadioGenix to produce Tc-99m in the U.S. RadioGenix gained FDA clearance in 2018, making NorthStar the first U.S. source of Mo-99 in almost three decades.
The deal also comes amidst the near completion of NorthStar’s Accelerator Production facility expansion in Beloit, Wisconsin. The aim of the expansion is to create a sustainable, domestic Mo-99 supply in the U.S. through dual production and processing hubs for additional capacity and scheduling flexibility.
FDA clears Siemens whole-body PET/CT scanner
In March, Siemens Healthineers has announced FDA clearance of its Biograph Vision Quadra PET/CT scanner, which has an extended axial field of view (FoV) that allows for simultaneous whole-body imaging from top of head to thigh.